{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:27:44Z","timestamp":1780450064208,"version":"3.54.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":4907,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2002,7]]},"DOI":"10.1046\/j.1523-1755.2002.00435.x","type":"journal-article","created":{"date-parts":[[2002,7,28]],"date-time":"2002-07-28T21:44:13Z","timestamp":1027892653000},"page":"253-260","source":"Crossref","is-referenced-by-count":102,"title":["Role of cyclooxygenase-2 in hyperprostaglandin E syndrome\/antenatal Bartter syndrome"],"prefix":"10.1016","volume":"62","author":[{"given":"Stephan C.","family":"Reinalter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikola","family":"Jeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Brochhausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Watzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf M.","family":"N\u00fcsing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannsj\u00f6rg W.","family":"Seyberth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"K\u00f6mhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0010","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/ng0696-183","article-title":"Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2","volume":"13","author":"Simon","year":"1996","journal-title":"Nat Genet"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0015","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ng1096-152","article-title":"Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK","volume":"14","author":"Simon","year":"1996","journal-title":"Nat Genet"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0020","first-page":"17","article-title":"Mutations in the gene encoding the inwardly-rectifying renal potassium channel, ROMK, cause the antenatal variant of Bartter syndrome: evidence for genetic heterogeneity","volume":"6","author":"The International Collaborative Study Group for Bartter-like Syndromes","year":"1997","journal-title":"Hum Molec Gen"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0025","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1172\/JCI118844","article-title":"Expression of the mouse Na-K-2Cl cotransporter, mBSC2, in the terminal inner medullary collecting duct, the glomerular, and extraglomerular mesangium, and the glomerular afferent arteriole","volume":"98","author":"Kaplan","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0030","doi-asserted-by":"crossref","first-page":"F739","DOI":"10.1152\/ajprenal.1997.273.5.F739","article-title":"Localization of the ROMK protein on apical membranes of rat kidney nephron segments","volume":"273","author":"Xu","year":"1997","journal-title":"Am J Physiol (Renal Physiol 42)"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0035","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0002-9343(01)01086-5","article-title":"Clinical presentation of gentically defined patients with hypokalemic salt-losing tubulopathies","volume":"112","author":"Peters","year":"2002","journal-title":"Am J Med"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0040","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0022-3476(96)70116-6","article-title":"Impaired response to furosemide in hyperprostaglandin E syndrome: Evidence for a tubular defect in the Loop of Henle","volume":"129","author":"K\u00f6ckerling","year":"1996","journal-title":"J Pediatr"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0045","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0022-3476(85)80395-4","article-title":"Congenital hypokalemia with hypercalciuria in preterm infants: A hyperprostaglandinuric tubular syndrome different from Bartter syndrome","volume":"107","author":"Seyberth","year":"1985","journal-title":"J Pediatr"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0050","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ng752","article-title":"Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure","volume":"29","author":"Birkenhager","year":"2001","journal-title":"Nat Genet"},{"issue":"6863","key":"10.1046\/j.1523-1755.2002.00435.x_bb0055","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/35107099","article-title":"Barttin is a Cl- channel beta-subunit crucial for renal Cl- reabsorption and inner ear K+ secretion","volume":"29;414","author":"Estevez","year":"2001","journal-title":"Nature"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0060","series-title":"Pfl\u00fcgers Arch (Eur J Physiol)","article-title":"Bartter syndrome with sensorneural deafness due to disturbed activation of CIC chloride channels by parttin","author":"Waldegger","year":"2002"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0065","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/ajmg.1320590411","article-title":"Infantile variant of Bartter syndrome and sensorineural deafness: a new autosomal recessive disorder","volume":"59","author":"Landau","year":"1995","journal-title":"Am J Med Genet"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0070","series-title":"Pediatrics 108(1)","first-page":"1","article-title":"Hypokalemic salt-losing tubulopathy with chronic renal failure and sensorineural deafness","author":"Jeck","year":"2001"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0075","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/ki.1976.33","article-title":"Bartter's syndrome with hyperplasia of renomedullary cells: successful treatment with indomethacin","volume":"9","author":"Verberckmoes","year":"1976","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0080","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0002-9343(76)90029-2","article-title":"Bartter's syndrome: A disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis","volume":"61","author":"Gill","year":"1976","journal-title":"Am J Med"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0085","series-title":"Oxford Textbook of Clinical Nephrology edited by Davison AM, Cameron JS, Gr\u00fcnfeld J-P, Kerr DNS, Ritz E, Winearls CG","first-page":"1085","article-title":"Hypokalaemic tubular disorders: The hyperprostaglandin E syndrome and the Gitelman-Bartter syndrome,","author":"Seyberth","year":"1998"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0090","series-title":"The Kidney","first-page":"754","article-title":"Arachidonic acid metabolites and the kidney,","author":"Breyer","year":"1996"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0095","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/S0002-9343(97)00203-9","article-title":"Mechanism of action of nonsteroidal anti-inflammatory drugs","volume":"104","author":"Vane","year":"1998","journal-title":"Am J Med"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0100","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0005-2760(95)00194-8","article-title":"Prostaglandin synthase 2","volume":"1299","author":"Herschman","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0105","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1172\/JCI117620","article-title":"Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction","volume":"94","author":"Harris","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0110","first-page":"F18","article-title":"Cloning, expression, and regulation of rabbit cyclooxygenase-2 in renal medullary interstitial cells","volume":"273","author":"Guan","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0115","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0085-2538(15)46757-2","article-title":"Cyclooxygenase-2-selective inhibitors impair glomerulogenesis and renal cortical development","volume":"57","author":"K\u00f6mhoff","year":"2000","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0120","doi-asserted-by":"crossref","first-page":"F119","DOI":"10.1152\/ajprenal.2001.280.1.F119","article-title":"Acute upregulation of COX-2 by renal artery stenosis","volume":"280","author":"Mann","year":"2001","journal-title":"Am J Physiol (Renal Physiol"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0125","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1523-1755.2001.00466.x","article-title":"Furosemide stimulates macula densa cyclooxygenase-2 expression in rats","volume":"59","author":"Mann","year":"2001","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0130","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1046\/j.1523-1755.2000.00425.x","article-title":"Cyclooxygenase-2 expression is associated with the renal macula densa of patients with Bartter-like syndrome","volume":"58","author":"K\u00f6mhoff","year":"2000","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0135","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0009-9236(01)78384-1","article-title":"Pathogenetic role of cyclooxygenase-2 in hyperprostaglandin E syndrome\/antenatal Bartter syndrome: Therapeutic use of COX-2 inhibitor nimesulide","volume":"70","author":"N\u00fcsing","year":"2001","journal-title":"Clin Pharm Ther"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0140","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1056\/NEJM200008313430915","article-title":"New treatment options for Bartter's syndrome","volume":"343","author":"Kleta","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0145","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/cpt1978236658","article-title":"Relation between plasma concentration of indomethacin and its effects on prostaglandin synthesis and platelet aggregation in man","volume":"23","author":"Rane","year":"1978","journal-title":"Clin Pharmacol Ther"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0150","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0378-4347(93)E0408-I","article-title":"Determination of seven prostanoids in 1 ml of urine by gas chromatography-negative ion chemical ionization triple stage quadrupole mass spectrometry","volume":"652","author":"Schweer","year":"1994","journal-title":"J Chromatogr B"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0155","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0090-6980(76)90160-X","article-title":"Quantification of the major urinary metabolite of the E prostaglandins by mass spectrometry: Evaluation of the method's application to clinical studies","volume":"11","author":"Seyberth","year":"1976","journal-title":"Prostaglandins"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0160","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1073\/pnas.96.1.272","article-title":"Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2","volume":"96","author":"McAdam","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0165","first-page":"1705","article-title":"Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases","volume":"271","author":"Patrignani","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0170","first-page":"623","article-title":"Differential inhibition of human prostaglandin endoperoxide synthase-1 and \u20132 by nonsteroidal anti-inflammatory drugs","volume":"48","author":"Patrignani","year":"1997","journal-title":"J Physiol Pharmacol"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0175","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0021-9673(01)92018-7","article-title":"High-speed liquid chromatographic analysis of indomethacin in plasma","volume":"114","author":"Skellern","year":"1975","journal-title":"J Chomatogr"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0180","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0378-4347(99)00565-4","article-title":"Determination of rofecoxib (MK-0966), a cyclooxygenase-2 inhibitor, in human plasma by high-performance liquid chromatography with tandem mass spectrometric detection","volume":"748","author":"Chavez-Eng","year":"2000","journal-title":"J Chomatrogr B"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0185","first-page":"954","article-title":"Synthesis and biological activaty of 2,3- and 3,4-diarylfurans and 2,3,4-triaryl-2,5-dihydrofurans","volume":"29B","author":"Dikshit","year":"1999","journal-title":"Indian J Chem"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0190","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s002280050736","article-title":"Pharmacokinetics, COX-2 specificity, and tolerability of supratherapeutic doses of rofecoxib in humans","volume":"56","author":"Depr\u00e9","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0195","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0092-8674(95)90125-6","article-title":"Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse","volume":"83","author":"Morham","year":"1995","journal-title":"Cell"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0200","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/S0140-6736(99)03105-0","article-title":"Neonatal end-stage renal failure associated with maternal ingestion of cyclo-oxygenase-type-2 selective inhibitor nimesulide as tocolytic","volume":"354","author":"Peruzzi","year":"1999","journal-title":"Lancet"},{"issue":"1 Pt 2","key":"10.1046\/j.1523-1755.2002.00435.x_bb0205","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/01.HYP.29.1.297","article-title":"Cyclooxygenase-2 mediates increased renal renin content induced by low-sodium diet","volume":"29","author":"Harding","year":"1997","journal-title":"Hypertension"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0210","doi-asserted-by":"crossref","first-page":"F481","DOI":"10.1152\/ajprenal.1998.274.3.F481","article-title":"Regulation of cyclooxygenase expression in the kidney by dietary salt intake","volume":"274","author":"Yang","year":"1998","journal-title":"Am J Physiol (Renal Physiol"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0215","series-title":"Am J Physiol (Renal Physiol 279)","first-page":"F819","article-title":"Renin expression in COX-2-knockout mice on normal or low-salt diets","author":"Yang","year":"2000"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0220","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0009-9236(99)70056-1","article-title":"Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects","volume":"66","author":"Rossat","year":"1999","journal-title":"Clin Pharm Ther"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0225","doi-asserted-by":"crossref","first-page":"37922","DOI":"10.1074\/jbc.M006218200","article-title":"Low chloride stimulation of prostaglandin E2 release and cyclooxygenase-2 expression in a mouse macula densa cell line","volume":"275","author":"Yang","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0230","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1172\/JCI10318","article-title":"Role of p38 in the regulation of renal cortical cycooxygenase-2 expression by extracellular chloride","volume":"106","author":"Cheng","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0235","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1242\/jeb.202.3.219","article-title":"Cellular control of renin secretion","volume":"202","author":"Kurtz","year":"1999","journal-title":"J Exp Biol"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0240","series-title":"Am J Physiol (Renal Physiol 279)","first-page":"F12","article-title":"Prostaglandin E receptors and the kidney","author":"Breyer","year":"2000"},{"key":"10.1046\/j.1523-1755.2002.00435.x_bb0245","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s001090000089","article-title":"Regulation of renin: New evidence from cultured cells and genetically modified mice","volume":"78","author":"Bader","year":"2000","journal-title":"J Mol Med"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815485436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815485436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T22:01:25Z","timestamp":1622066485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815485436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,7]]}},"alternative-id":["S0085253815485436"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-1755.2002.00435.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2002,7]]}}}